Image: Vicky Roulstone is studying for a PhD funded by the Oracle Cancer Trust

Oracle Cancer Trust provides grants to fund research projects that pioneer head and neck cancer research. Their commitment supports PhD students and Post-Doctoral Researchers to focus on head and neck cancer.

Head and neck cancer is one of the fastest forms of cancer and is the sixth most common type of cancer in the UK.

Oracle Cancer Trust funds a variety of studies including a thyroid cancer research group, immuno and virus therapies, imaging, combination drug therapies and developing treatment algorithms for the new MR Linac imaging machine based at The Royal Marsden Hospital in Sutton.

Oracle Cancer Trust has funded over £1m in grants over the past five years and will continue to support the ICR in discovering smarter, kinder treatments for patients.

Supporting innovative approaches

Professor Kevin Harrington, Joint Head of the Division of Radiotherapy and Imaging, The Institute of Cancer Research, who supervises the Oracle Cancer Trust project says:

“The partnership between the ICR and Oracle allows researchers to develop an array of new treatment strategies which have the potential to make a real difference for patients with head and neck and thyroid cancers.

“In particular, Oracle has the courage and foresight to support innovative approaches form their inception through to the point where researchers are able to win competitive funding from major grant-awarding bodies. In this regard, Oracle is making a unique contribution to changing the research landscape for patients with head and neck cancers.”